ArticleEye (London, England)2025
Defining the limits of upper and lower conjunctival fornix depths in a healthy Asian Chinese population.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe early detection of conjunctival fornix shortening is essential for the effective management of progressive cicatrising conjunctival diseases. Establishing a baseline reference for conjunctival scarring by determining the normative conjunctival fornix depths (FDs) allows for the measurement and monitoring of changes in the conjunctiva. This study explored anatomical variations in conjunctival FDs amongst an Asian Chinese population, providing valuable information for conjunctival fibrosis assessment.
methodsThis retrospective study conducted at a single centre included 295 Chinese individuals (590 eyes) with normal conjunctiva who visited the eye clinic between 2019 and 2023. The lower and upper FDs were assessed using a validated FD measurer (FDM). Mean lower and upper FDs were calculated and stratified by age and gender.
resultsThe mean upper and lower conjunctival FDs for the Chinese population in Singapore were 16.1 mm ± 1.6 (95% CI, 15.9-16.2) and 10.1 mm ± 1.7 (95% CI, 10.0-10.3), respectively. Females exhibited shorter FDs (upper 15.7 mm ± 1.5; lower 9.8 mm ± 1.5) compared to males (upper 16.5 mm ± 1.5; lower 10.5 mm ± 1.9) (p < 0.001). Linear regression analysis demonstrated a significant inverse correlation between age and FDs, indicating that FDs decreases with advancing age (R² = 0.1469 for upper and 0.3195 for lower fornices; p < 0.001). Specifically, the mean upper FD ranged from 17.4 mm (95% CI, 17.2-17.7) in the 20-29 age group to 15.2 mm (95% CI, 14.9-15.5) in the 80-89 age group. Similarly, the mean lower FD ranged from 12.0 mm (95% CI, 11.6-12.4) in the 20-29 age group to 8.7 mm (95% CI, 8.5-9.0) in the 80-89 age group. Analysis of the 95% CIs revealed no statistical difference in FD measurements when compared to published Caucasians, South Asians, and Turkish populations.
conclusionsThis study adds to the available literature a set of normative data for upper and lower FD in a Chinese population, highlighting gender-related variations and age-related progressive conjunctival shrinkage. The established dataset serves as a valuable resource for clinicians, enabling them to better manage and monitor patients with conjunctival diseases. These normative values in forniceal depths adds to available data obtained from Caucasian, South Asian, and Turkish eyes. Existing clinical assessment tools incorporating FD measurements, but validated in other ethnic populations, can be used in Chinese populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.